Study to Assess Length of Remission With Intensive Chemotherapy in Rapidly Responding AML Patients.
Clinical trial NCT03902769 · UNKNOWN
Trial details
- NCT number
- NCT03902769
- Sponsor
- Rambam Health Care Campus
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-15
- Primary completion
- 2021-11-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.